<?xml version="1.0" encoding="UTF-8"?>
<p>THCA inhibited cell proliferation in various prostate carcinoma cell (PCC) lines, including (i) androgen-receptor positive cells (LNCaP and 22RV1) with IC
 <sub>50</sub> of 22.1 ± 2 µM or 17.1 ± 1 µM in the presence or absence of serum, respectively, (ii) androgen-receptor negative cells (DU-145 and PC-3) with IC
 <sub>50</sub> of &gt;25 µM (21.9% inhibition) or 21.6 ± 2 µM in the presence or absence of serum, respectively [
 <xref rid="B62-ijms-21-09049" ref-type="bibr">62</xref>]. Cell proliferation of two different human breast carcinoma (HBC) cells, triple-negative MDA-MB-231 and HER2-negative MCF-7, were inhibited with IC
 <sub>50</sub> value of 18.2 ± 5 µM and 9.8 ± 0.4 µM, respectively [
 <xref rid="B61-ijms-21-09049" ref-type="bibr">61</xref>].
</p>
